CausalSentinel

Protein Dossier — MAPKAPK2 (MAP kinase-activated protein kinase 2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Ulcerative colitis 0.23 0.0421 4.84e-08 Wald ratio 1 cis NA
Inflammatory bowel disease 0.169 0.0336 4.63e-07 Wald ratio 1 cis NA
Childhood intelligence -0.143 0.0423 7.53e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: mania or bipolar disorder or manic depression 0.358 0.112 0.00138 Wald ratio 1 cis NA
Diagnoses - main ICD10: N20 Calculus of kidney and ureter 0.207 0.0784 0.0083 Wald ratio 1 cis NA
Crohn’s disease 0.0945 0.0407 0.0202 Wald ratio 1 cis NA
Chronic kidney disease 0.113 0.0491 0.0208 Wald ratio 1 cis NA
Multiple sclerosis -0.126 0.0548 0.0213 Wald ratio 1 cis NA
Diagnoses - main ICD10: R14 Flatulence and related conditions 0.495 0.216 0.0217 Wald ratio 1 cis NA
High grade serous ovarian cancer -0.113 0.0515 0.0283 Wald ratio 1 cis NA
Diagnoses - main ICD10: L03 Cellulitis 0.165 0.0765 0.031 Wald ratio 1 cis NA
Non-cancer illness code self-reported: diverticular disease or diverticulitis 0.143 0.0663 0.031 Wald ratio 1 cis NA
…and 107 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3820_68_2 MAPK2 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

14 association rows across 10 traits (10 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
MAP kinase-activated protein kinase 2 levels 8e-129 rs10863805 2 GCST90248478 no MR -> candidate analysis
MAPKAPK2 protein levels 6e-86 rs11119390 1 GCST90469858 no MR -> candidate analysis
Height 6e-40 rs4311892 2 GCST90245848 no MR -> candidate analysis
Mouth ulcers 1e-19 rs3813961 1 GCST007839 no MR -> candidate analysis
IL19 protein levels 8e-19 rs782170878 1 GCST90469568 no MR -> candidate analysis
Mitogen-activated protein kinase 14 levels 3e-18 rs11119385 1 GCST90248407 no MR -> candidate analysis
Mean corpuscular hemoglobin 2e-12 rs45514798 2 GCST90002390 no MR -> candidate analysis
Crohn’s disease 3e-7 rs61815628 2 GCST90301327 MR: beta=0.0945, p=0.0202 (cis)
Crohn’s disease x sex interaction (2df) 4e-7 rs61815628 1 GCST90301328 no MR -> candidate analysis
Plasma PCSK9 levels 9e-7 rs17015194 1 GCST90085917 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 400 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
migraine disorder 0.553 common-variant locus no MR -> candidate analysis
glomerulonephritis 0.459 common-variant locus no MR -> candidate analysis
sialolithiasis 0.363 common-variant locus no MR -> candidate analysis
neurodevelopmental disorder 0.195 established (curated) no MR -> candidate analysis
type 2 diabetes mellitus 0.085 common-variant locus no MR -> candidate analysis
diabetes mellitus 0.085 common-variant locus no MR -> candidate analysis

Of the 6 rows above, 6 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 1 known modulators (MAP kinase-activated protein kinase 2)
gnomAD constraint pLI=1, LOEUF=0.322 — LoF-INTOLERANT
GWAS Catalog 57 unique SNPs / 114 rows
ClinVar 77 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance